The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Clinical differences between idiopathic and scleroderma‐related pulmonary hypertension
Abstract
Objective: Pulmonary arterial hypertension related to scleroderma (PAH‐Scl) is associated with high morbidity and mortality as well as poorer response to therapy and worse outcomes compared with the idiopathic form of PAH (IPAH). Scleroderma is an autoimmune disease that can affect left and right heart function directly through inflammation and fibrosis and indirectly through systemic and pulmonary hypertension. This study tested the hypothesis that an increased prevalence of left heart disease might explain the higher mortality in patients with PAH‐Scl compared with patients with IPAH. Methods: The study was designed as a retrospective cohort study comparing the baseline clinical data from 91 consecutive patients (41 with IPAH and 50 with PAH‐Scl). Cox proportional hazards models were used to predict the effect of clinical covariates on patient survival. Results: Patients with PAH‐Scl had a lower mean pulmonary artery pressure (46.6 mm Hg versus 54.4 mm Hg in patients with IPAH; P = 0.002) despite similar levels of cardiac dysfunction (cardiac index 2.2 and 2.1 liters/minute/m 2, respectively; P = 0.19). Echocardiography revealed similar degrees of right ventricular dysfunction in the 2 groups, whereas a predominance of left heart dysfunction was observed in patients with PAH‐Scl. One‐ and three‐year survival estimates were 87.8% and 48.9%, respectively, in patients with PAH‐Scl and 95.1% and 83.6%, respectively, in those with IPAH. Patients with PAH‐Scl were 3.06 times more likely to die than were patients with IPAH, after controlling for the presence of pericardial effusion; there was no significant change in increased risk of death in PAH‐Scl after controlling for left heart disease. Conclusion: The results confirm that there are significant clinical and survival differences between IPAH and PAH‐Scl. The presence of left heart disease, although more common in PAH‐Scl, was not predictive of the higher mortality in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Mayes, M. D., Lacey, J. V., Beebe‐Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., & Schottenfeld, D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11073 · Cited by 935
Medical Therapy For Pulmonary Arterial Hypertension
Badesch, D. B., Abman, S. H., Ahearn, G. S., Barst, R. J., McCrory, D. C., Simonneau, G., & McLaughlin, V. V. (2004) · Chest · doi:10.1378/chest.126.1_suppl.35s · Cited by 829
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Raymond, R. J., Hinderliter, A. L., Willis, P. W., Ralph, D., Caldwell, E. J., Williams, W., Ettinger, N. A., Hill, N. S., Summer, W. R., de Boisblanc, B., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01744-8 · Cited by 827
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Hassoun, P. M., Mouthon, L., Barberà, J. A., Eddahibi, S., Flores, S. C., Grimminger, F., Jones, P. L., Maitland, M. L., Michelakis, E. D., Morrell, N. W., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.006 · Cited by 710
Self-citationConnective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Condliffe, R., Kiely, D. G., Peacock, A. J., Corris, P. A., Gibbs, J. S. R., Vrapi, F., Das, C., Elliot, C. A., Johnson, M., DeSoyza, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-953oc · Cited by 657
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Thenappan, T., Shah, S. J., Rich, S., Tian, L., Archer, S. L., & Gomberg-Maitland, M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00072709 · Cited by 493
Champion, H. C., Michelakis, E. D., & Hassoun, P. M. (2009) · Circulation · doi:10.1161/circulationaha.106.674028 · Cited by 468
Self-citationASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Hurdman, J., Condliffe, R., Elliot, C. A., Davies, C., Hill, C., Wild, J. M., Capener, D., Sephton, P., Hamilton, N., Armstrong, I. J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00078411 · Cited by 459
A USA-based registry for pulmonary arterial hypertension: 1982–2006
Thenappan, T., Shah, S. J., Rich, S., & Gomberg-Maitland, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042107 · Cited by 432
Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL
Chung, L., Liu, J., Parsons, L., Hassoun, P. M., McGoon, M., Badesch, D. B., Miller, D. P., Nicolls, M. R., & Zamanian, R. T. (2010) · Chest · doi:10.1378/chest.10-0260 · Cited by 431
Self-citation2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Noordegraaf, A. V., Beghetti, M., et al. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.01.002 · Cited by 357
AVOUAC, J., AIRÒ, P., MEUNE, C., BERETTA, L., DIEUDE, P., CARAMASCHI, P., TIEV, K., CAPPELLI, S., DIOT, E., VACCA, A., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100245 · Cited by 333
Solomon, J. J., Olson, A. L., Fischer, A., Bull, T., Brown, K. K., & Raghu, G. (2013) · European Respiratory Review · doi:10.1183/09059180.00005512 · Cited by 294
Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension
Tedford, R. J., Mudd, J. O., Girgis, R. E., Mathai, S. C., Zaiman, A. L., Housten-Harris, T., Boyce, D., Kelemen, B. W., Bacher, A. C., Shah, A. A., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000008 · Cited by 289
Self-citationLefèvre, G., Dauchet, L., Hachulla, E., Montani, D., Sobanski, V., Lambert, M., Hatron, P., Humbert, M., & Launay, D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38029 · Cited by 274
Mathai, S. C., Hummers, L. K., Champion, H. C., Wigley, F. M., Zaiman, A., Hassoun, P. M., & Girgis, R. E. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24267 · Cited by 265
Self-citation
Metadata
- Authors
- Fisher, M. R., Mathai, S. C., Champion, H. C., Girgis, R. E., Housten‐Harris, T., Hummers, L., Krishnan, J. A., Wigley, F., & Hassoun, P. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-08-31
- Volume
- 54
- Issue
- 9
- Pages
- 3043-3050
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2069038734
- Cited by
- 349
- References
- 24
- FWCI
- 16.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.